In accordance with TechFlow, on September 23, US-listed Scilex Holding Company announced that it has signed a securities purchase agreement with an institutional investor to exchange $200 million worth of common shares in its subsidiary, Semnur Pharmaceuticals, Inc., for an equivalent amount of Bitcoin. Under the terms of the agreement, Scilex Holding's shares in Semnur Pharmaceuticals will be swapped with the institutional investor at a $200 million valuation for Bitcoin.
US Listed Scilex Holding to Swap $200M in Subsidiary Shares for Equivalent Bitcoin
KuCoin NewsShare
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.